Razorfish Health Named to MM+M Agency 100 2025 List

New York City, June 11, 2025 — Razorfish Health (RFH) has been named to the MM+M Agency 100 List for 2025, marking a significant achievement for the company and highlighting its continued impact in healthcare marketing.

Annually, MM+M evaluates progress and growth in the industry by ranking the top 100 medical marketing agencies in North America. The MM+M Agency 100 serves as a valuable resource for medical marketing leaders, highlighting best practices and industry benchmarks.

Razorfish Health’s investments in science and strengthening of its core capabilities paid off with a large MedComms/Med Affairs win and new high-science engagements. This fueled double-digit growth in 2024 and elevated its agency of record (AOR) list to 30.

“Our differentiation is really our love for science and translating that into growth,” said Razorfish Health President Kara Dugan.

See Razorfish Health’s full profile here: Razorfish Health MM+M Agency 100 2025